Medics at Covid care centre at CWC, in New Delhi
The Union Health Ministry on Thursday issued a revised 'Clinical Guidance for Management of Adult Covid-19 Patients' recommending the EUA/off-label use of Tocilizumab drug in case of severe diseases, preferably within 24 to 48 hours of the onset of the disease or ICU admission.
Read:Clinical guidance for management of adult covid-19 patients - April 22, 2021
Published on April 23, 2021